top of page
Screen Shot 2021-01-07 at 1.52_edited.jpg

Laser focused on improving the quality of life for millions of people by building revolutionary technology to image and treat vitreoretinal disease.

PulseMedica logo

The Problem

Over 500 Million People Suffer From Eye Disease

Diseases such as age-related macular degeneration (AMD), diabetic retinopathy, branch retinal vein occlusion, vitreomacular traction, and glaucoma affect hundreds of millions of people worldwide. While some of these conditions don't have an effective treatment option, others require monthly eye injections to reduce disease progression. 

eye injection_edited.jpg

Our Solution

PulseMedica is developing a medical device platform that enables safe, effective and non-invasive treatment of various eye diseases. Our platform leverages advanced imaging technology, embedded machine learning and laser technology to precisely diagnose, plan and treat diseased areas within the eye. Our platform will revolutionize existing treatments for eye diseases while also unlocking novel treatment options that currently do not exist.

Recent News


January 26, 2024

PulseMedica is Laser-Focused on Tackling Vitreoretinal Diseases

PulseMedica aims to transform vitreoretinal disease outcomes in the blink of an eye.

by Alberta Innovates

January 11, 2024

AICE Validate Program Success Story

Alberta Innovates supports companies like PulseMedica as they develop technology to make our lives better.


April 4, 2022

PulseMedica closes $2.6M seed round

Early-stage financing for Canadian startup developing ultrafast laser treatment of several eye diseases.

bottom of page